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Abstract
The relation of white matter hyperintense lesions to episodic memory impairment in patients with Parkinson’s disease (PD) is still
controversial. We aimed at evaluating the relation between white matter hyperintense lesions and episodic memory decline in
patients with PD. In this multicentric prospective study, twenty-one normal controls, 15 PD patients without mild cognitive
impairment (MCI) and 13 PD patients withMCI were selected to conduct a clinico-radiological correlation analysis. Performance
during episodic memory testing, age-related white matter changes score, total manual and automated white matter hyperintense
lesions volume and lobar white matter hyperintense lesions volumes were compared between groups using the Kruskal-Wallis
and Wilcoxon signed-rank tests, and correlations were assessed using the Spearman test. MCI PD patients had impaired free
recall. They also had higher total, left prefrontal and left temporal white matter hyperintense lesions volumes than normal
controls. Free recall performance was negatively correlated with the total white matter hyperintense lesions volume, either
manually or automatically delineated, but not with the age-related white matter changes score. Using automated segmentation,
both the left prefrontal and temporal white matter hyperintense lesions volumes were negatively correlated with the free recall
performance. Early episodic memory impairment inMCI PD patients may be related to white matter hyperintense lesions, mainly
in the prefrontal and temporal lobes. This relation is influenced by the method used for white matter hyperintense lesions
quantification. Automated volumetry allows for detecting those changes.
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Introduction
Cognitive dysfunction in elderly subjects may be linked to white
matter hyperintense lesions (WMHL) related to cerebral small
vessel disease (CSVD) (Zhou et al. 2015; Maillard et al. 2012;
Smith et al. 2011). In elderly hypertensive patients with subjec-
tive memory complaints, higher WMHL volume has been cor-
relatedwith lower greymatter metabolism, independently of age,
gender or grey matter atrophy (Verger et al. 2016). Higher
WMHL load has also been reported in mild cognitive impaired
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(MCI) and demented patients with Parkinson’s disease (PD)
(Beyer et al. 2006; Kandiah et al. 2013; Lee et al. 2010; Mak
et al. 2015; Slawek et al. 2013; Sunwoo et al. 2014). Episodic
memory (EM) is early impaired in PD and may be a risk factor
for future cognitive decline (Broeders et al. 2013). The impact of
CSVD on EM is however still inconclusive, notably in old-age
onset PD patients. A recent critical review of the pertinent liter-
ature (Vesely and Rektor 2016) suggested that the controversial
results on the contribution of WMHL to cognitive decline in PD
might be due to differences in methods of cognitive testing and
WMHL load assessment from MRI.
WMHL load can be evaluated either by visual rating or
quantitative methods. While visual rating and WMHL volume
have been well correlated (Kapeller et al. 2003) and present
good interrater reliability (Olsson et al. 2013), an automatized
volumetric method for measuringWMHL load is more suitable
for evaluating progression of the disease (Prins et al. 2004).
WMHL volume on fluid-attenuated inversion recovery
(FLAIR) images may be delineated manually, using semi-
automated (Dalaker et al. 2009) or fully-automated software
(Fartaria et al. 2016; Gibson et al. 2010), this latter demonstrat-
ing high accuracy. We thus hypothesized in the present study
that early EM decline in elderly MCI patients with newly diag-
nosed PD could be due to CSVD and that this relation could be
influenced by the employed WMHL quantification method.
The aim of the study was to evaluate the relation between
WMHL load and EM testing in patients older than 70 years
with newly diagnosed PD as well as the impact of theWMHL
evaluation method on this interrelation.
Materials and Methods
Study population
From December 2011 to June 2016, 27 healthy controls (mean
age: 77.6 ± 3.2 years; male: 20) and 67 patients (mean age:
79.6 ± 4.7 years; male: 35) were prospectively enrolled in this
multicentric study. Inclusion criteria for patients were: age be-
tween 70 and 90 years, symptoms of parkinsonism starting
after the age of 70 years, no history of cardiovascular disease.
Inclusion criteria for controls were: age between 70 and
90 years, no parkinsonian symptoms, no history of cardiovas-
cular disease. Exclusion criteria were identical for all subjects
(controls and patients) and included: previous history of head
injury, stroke, neuroinflammatory disorders, myocardial in-
farct, intra-cranial bleeding, exposure to neuroleptic drugs, psy-
chiatric comorbidity, contraindications to MRI. In order to rule
out stroke, intra-cranial bleeding or neuroinflammatory disor-
ders related sequelae, brain MRI or CT examinations available
on the institutional image archiving system before inclusion as
well as MRI scans performed during the study were reviewed
by a neuroradiologist who was not involved in the MRI data
processing. All participants underwent brain MRI, a neurolog-
ical examination to determine the parkinsonism’s subtype and a
neuropsychological assessment including EM testing within
the same day. The mean delay between patients’ inclusion
and clinico-radiological evaluation was 9.4 ± 42.4 days.
Ethical approval
This studywas approved by the Institutional ReviewBoard and
conformed with the World Medical Association Declaration of
Helsinki. The experiments were undertaken with understand-
ing and written informed consent of each subject.
Clinical assessment
All participants underwent a neurological and neuropsycho-
logical evaluation on the day of brain MRI. Diagnoses were
established by a neurologist experienced in parkinsonian syn-
dromes, blinded to the MRI results and according to the fol-
lowing established guidelines: the UK Parkinson’s Disease
Society Brain Bank criteria for idiopathic PD, the National
Institute of Neurological Disorders and Stroke and the
Society for Progressive Supranuclear Palsy (PSP) criteria for
PSP, Zijlmans’s criteria along with multiple cardiovascular
risk factors and minimal or absent Levodopa response for
vascular parkinsonism (VP), the Gilman’s criteria for multiple
system atrophy (MSA), and the Lang criteria for corticobasal
dementia (CBD) as previously reported (Dunet et al. 2016).
Neuropsychological assessment included testing of five
cognitive domains: attention and working memory, executive
functions, language, visuospatial abilities and episodic memo-
ry. Global cognitive efficiency was assessed using the Mini
Mental State Examination (MMSE) score (range 0–30) and
the Mattis Dementia Rating Scale (range 0–144), which in-
volves five subsets (attention, initiation, construction, concep-
tualization, andmemory). Attention andworkingmemorywere
assessed with a auditory-verbal forward and backward span
task and the Delis-Kaplan Executive Function System (D-
KEFS) TrailMaking Test evaluating flexibility; executive func-
tions were assessed with the Frontal Assessment Battery, the
french version of the Stroop Victoria test evaluating inhibition,
the D-KEFS Trail Making Test evaluating flexibility, the Rey
complex figure copy test evaluating planification abilities and
the clock-drawing test; language was evaluated with the LEXIS
and Isaac’s Set tests; visuospatial functions were assessed with
the Rey complex figure copy test. Finally, to assess EM, we
used the free/cued recall selective reminding test (FCSRT)
(Grober et al. 2010). After a training phase that controls verbal
attention and semantic encoding, the study includes three trials
of recall for 16 items, separated by 20 s of interference, to
explore retrieval. Each trial of recall consists of free recall
followed by cued recall. A single delayed free/cued recall trial
is finally performed 20 min later. Neuropsychological metrics
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were recorded as z-scores (free recall) or percentiles (cued re-
call) compared with results of a healthy population normalized
for age and gender. MCI patients were diagnosed according to
the Level I of the Movement Disorders Task Force guidelines
(Litvan et al. 2012) when at least two neuropsychological tests
in the five domains were impaired. The Educational Attainment
was also recorded.
Images acquisition and processing
All subjects underwent brain MRI on a 3 Tesla scanner
(MAGNETOM Skyra, Siemens Healthcare, Erlangen,
Germany) including an axial unenhanced T1-weighted mag-
netization-prepared rapid 3D gradient-echo (MPRAGE) se-
quence (repetition time = 1690 ms, echo time = 2.54 ms, in-
version time = 922 ms, turbo actor = 208, flip angle = 9°, slice
thickness = 1 mm, 176 slices, isotropic voxel size = 1 mm3)
and sagittal FLAIR sequence (repetition time = 5000 ms, echo
time = 384 ms, inversion time = 1800 ms, flip angle = 120°,
slice thickness = 0.9 mm, 160 slices, interpolated voxel size =
0.9 × 0.9 × 0.9 mm3).
WMHL loadwas evaluated by visual rating aswell as by both
manual and automated volume estimation at the patient level. For
visual rating, FLAIR images were reviewed by two neuroradiol-
ogists in consensus to measure the severity of cerebral age-
related white matter changes (ARWMC) by using the four-
point scale of the European Task Force: 0 (no lesion), 1 (focal
non confluent lesions ≥5 mm), 2 (beginning confluence of le-
sions) or 3 (diffuse involvement). For WMHL volume estima-
tion, WMHL were manually contoured on FLAIR images by a
single neuroradiologist with 8-years’ experience in neuroimaging
with the MRIcron software (https://www.nitrc.org/projects/
mricron). Volumes were recorded in milliliters (mL) and as per-
centage of the total intracranial volume. To ensure reproducibility
of the measure, delineation was repeated twice for ten subjects
randomly chosen, while respecting a delay of 3 months between
the two delineations. Mean delineation time was about 20 min
per case (1880 min for all participants).
Finally, WMHL volume was also computed using automated
prototype software initially designed forMultiple Sclerosis lesion
segmentation (Fartaria et al. 2016). The method consists of two
main steps: i) pre-processing, where the images are aligned,
skull-striped, corrected for bias field and intensity-normalized;
and ii) lesion segmentation, performed by a supervised classifier
based on k-nearest-neighbor (k-NN) algorithm. Lesion masks of
each subject were obtained through a Bleave-one-out^ cross-
validation on the whole cohort of 94 subjects (see section
Study population). Lobar WMHL volumes were estimated by
summing up voxels labelled as lesion tissue by the automated
algorithm over the left and right pre-frontal, frontal, temporal,
parietal and occipital masks obtained by atlas propagation
(Schmitter et al. 2015). The computation time for the automated
segmentation was 10 min per patient (940 min for all
participants) on a standard computer. T1-MPRAGE imageswere
also segmented to estimate the lobar (pre-frontal, frontal,
temporal, parietal, occipital) grey matter and hippocampus vol-
umes using the MorphoBox software (Schmitter et al. 2015).
Statistical analysis
All statistics were performedwith the Stata 13.1 software (Stata
Corp., College Station, TX, USA). Continuous variables are
presented as mean ± standard deviation. Statistical analysis
was performed in a two-step manner. First, the correlation
and concordance of the three methods to quantify WMHL for
all participants (n = 94) was evaluated by the Lin’s test and
Bland-Altman plot with computation of 95% limits-of-
agreement (LOA). Second, a clinico-radiological correlation
analysis was performed to identify if there was a significant
relation between high WMHL load and clinical assessment,
i.e. EM testing. For this analysis, three groups were considered:
normal controls (NC), PD patients without MCI (non-MCI
PD), and PD patients withMCI (MCI PD). Group comparisons
were performed using the Kruskal-Wallis and Wilcoxon tests
for continuous variables and the Fisher exact test for propor-
tions. The relation between each neuropsychological metric
(FCSRT and Mattis score) and total WMHL load (ARWMC
score, total manual and automated WMHL volumes) was
assessed by the non-parametric Spearman rho correlation coef-
ficient. We also evaluated the relation between the same neu-
ropsychological metrics and lobar (left/right prefrontal, frontal,
temporal, parietal, occipital) WMHL and grey matter (lobar
and hippocampus) volumes by the non-parametric Spearman
correlation coefficient. All correlation analyses were adjusted
for age and gender. An uncorrected p-value <0.05 was consid-
ered significant. For multiple correlation analyses, correction of
the significance level was performed using the Benjamini and
Hochberg method with a false discovery rate of 0.1 (Green and
Diggle 2007). For these multiple correlation analyses, only
results remaining significant after correction of the significance
level are reported in the text.
Results
Study population
Out of 67 patients who underwent MRI, thirty-four patients
met the criteria of idiopathic PD (mean age 79.9 ± 5.2yo;
male: 20), eight patients those of VP (mean age 78.0 ±
2.0yo; male: 7), seven patients those of PSP (mean age 79.6
± 6.7yo; male: 5), four patients those ofMSA (mean age: 79.5
± 3.8yo; male: 2), three patients those of CBD (mean age:
77.3 ± 4.0yo; male: 0), one met criteria for Lewy body demen-
tia (age: 76yo; male: 1), and ten could not yet be classified
(mean age: 80.9 ± 4.0yo; male: 4).
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Characteristics of subjects included in the clinico-
radiological correlation analysis are summarized in
Table 1. Out of the 27 controls, six with MCI were
excluded. Out of the 34 PD patients, six with dementia
were excluded. Overall, 21 NC, 15 non-MCI PD pa-
tients and 13 MCI PD patients were included. MCI
PD patients were older than NC (p = 0.0001). There
was no statistically significant difference regarding sex
ratio, educational level, time-from-onset of PD symp-
toms or dopaminergic therapy. MCI PD patients had
impaired free and cued recall, global memory, initiation
and conceptualization compared with NC (Table 2).
They did not have impaired verbal attention and seman-
tic encoding. Regarding grey matter, only occipital vol-
ume was lower in MCI PD patients than in NC (p =
0.014) and non-MCI PD patients (p = 0.019).
WMHL load estimation
On visual rating, eight subjects had score 0, 34 had score
1, 31 had score 2, and 21 had score 3. Mean total WMHL
volumes were 12.7 ± 13.5 mL and 12.5 ± 10.8 mL for
manual and automated segmentation, respectively. The
concordance between manually and automatically delin-
eated WMHL volumes was excellent (Pearson’s r =
0.974, rho_c = 0.950, C_b = 0.975, mean difference =
0.18 ± 3.9 mL, 95%LOA = −7.43–7.79, p = 0.65). Manual
delineation was highly reproducible (Pearson’s rho =
0.997, rho_c = 0.997, C_b = 0.999, mean difference =
0.07 ± 1.0 mL, 95%LOA = −1.9–2.1, p = 0.83). Both were
positively correlated with ARWMC score (rho = 0.90, p <
0.0001 and rho = 0.87, p < 0.0001 for manual and auto-
mated segmentation, respectively, Fig. 1).
Table 1 Characteristics of
subjects included in the clinico-
radiological correlation analysis
Characteristics NC, n = 21 Non-MCI PD, n = 15 MCI PD, n = 13 p-value
Clinical
Age (years) 76.7 ± 2.3 78.1 ± 6.1 81.8 ± 3.8* 0.0024
Gender (male/female) 15/6 10/5 7/6 0.60
Educational level (A/B/C/D) 4/3/3/11 3/2/2/8 5/1/1/6 0.88
BMI (kg/m2) 25.4 ± 3.5 27.4 ± 13.5 23.3 ± 2.1 0.21
Diabetes (no/yes) 20/1 12/3 12/1 0.42
Hypertension (no/yes) 10/11 9/6 8/5 0.72
Hypercholesterolemia (no/yes) 13/8 13/2 9/4 0.27
Smoking (no/yes) 9/12 8/7 9/4 0.32
Disease duration (years) – 5.7 ± 3.6 6.5 ± 5.1 0.80
Levodopa medication (no/yes) – 2/13 4/9 0.26
Daily dose (mg) – 639 ± 361 551 ± 236 0.87
Freezing of gait (on/off) – 10/5 7/6 0.70
Imaging
Total intracranial volume (mL) 1538 ± 135 1538 ± 178 1477 ± 142 0.61
ARWMC score (0–3) 1.4 ± 0.9 1.5 ± 0.8 1.9 ± 1.0 0.34






























































*p < 0.05 compared with NC. † p < 0.05 compared with non-MCI PD patients
For Educational level, A = End primary school certificate, B =Mid secondary school certificate, C = End second-
ary school certificate, D =University graduation. ARWMC = age-related white matter changes, BMI = body mass
index,MCI =mild cognitive impairment,NC = normal controls,PD = Parkinson’s disease,WMHL =white matter
hyperintense lesions
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ARWMC score was not different between groups while
total WMHL volumes tend to be higher in MCI PD patients
than in NC (p = 0.058 and p = 0.063 for manual and automat-
ed segmentation, respectively). Total WMHL volume was not
correlated with age in our cohort (rho =0.11, p = 0.45). Lobar
WMHL volumes are displayed in Table 1.
Clinico-radiological correlation
Detailed results of the correlation analysis between total WMHL
volume and neuropsychological metrics are displayed in Table 3.
ARWMC score was not correlated with any neuropsychological
metric. TotalWMHL volume estimated bymanual segmentation
was correlated with performance during the second cued recall.
Using automated segmentation, performances during the
second free recall were correlated with the left prefrontal
(rho = −0.37, p = 0.009) and left temporal (rho = −0.35, p =
0.016) WMHL volumes. Performances during the third free
recall were correlated with the left prefrontal (rho = −0.35, p =
0.014) and left temporal (rho = −0.39, p = 0.0058) WMHL
volumes. Delayed free recall performance was correlated with
the left prefrontal (rho = −0.37, p = 0.013) and left temporal
(rho = −0.43, p = 0.0035) WMHL volumes. Finally, the left
prefrontal WMHL volume was correlated with the Mattis
memory subscore (rho = −0.36, p = 0.013). Lobar grey matter
and hippocampus volumes were not correlated with any neu-
ropsychological metric (all corrected p > 0.15).
Discussion
In this prospective multicentric study focusing on subjects
older than 70 years, PD patients with MCI presented early
EM impairment, which was not present in normal controls.
EM decline correlated withWMHL volumes, especially in the
left prefrontal and temporal lobes, which were accurately
quantified by the automated lesion segmentation.
Relation between WMHL and cognitive decline
WMHL related to CSVD have been correlated with cognitive
dysfunction in elderly patients with (Malek et al. 2016) or with-
out PD (Zhou et al. 2015;Maillard et al. 2012; Smith et al. 2011).
In a large stroke-free population, WMHL was especially associ-
ated with worse memory in subjects older than 70 years, inde-
pendently of brain atrophy (Dong et al. 2015). Similarly, we
found that PD patients older than 70 years with MCI presented
early EM decline compared with NC, particularly during free
recall testing. MCI PD patients were older than NC but all neu-
ropsychological metrics were normalized for age and gender.
Thus, age-related confounds do not account for any of the ob-
served differences in EMperformance or for the relation between
EM and WMHL. Indeed, total WMHL volume was negatively
correlated with EM performance. Our findings thus confirm that
WMHL due to CSVD may result in worse EM also in subjects
older than 70 years with PD. This is in agreement with two other
studies (Kandiah et al. 2013; Lee et al. 2010), which
Table 2 Neuropsychological
tests Tests (normalized scores) NC, n = 21 Non-MCI PD, n = 15 MCI PD, n = 13 p-value
FCSRT
Immediate recall (percentiles) 42.1 ± 24.2 36.5 ± 24.4 29.3 ± 29.1 0.28
Free recall 1 (z-scores) 0.59 ± 1.07 0.13 ± 0.97 −0.28 ± 0.87* 0.065
Cued recall 1 (percentiles) 58.5 ± 25.2 54.9 ± 28.8 36.4 ± 27.1* 0.085
Free recall 2 (z-scores) 1.03 ± 0.68 0.04 ± 0.99 −0.34 ± 0.84* 0.0003
Cued recall 2 (percentiles) 53.6 ± 18.2 47.9 ± 26.2 35.1 ± 26.9* 0.12
Free recall 3 (z-scores) 0.75 ± 0.74 −0.02 ± 1.05 −0.44 ± 1.23* 0.0076
Cued recall 3 (percentiles) 33.0 ± 19.9 35.8 ± 22.8 35.4 ± 30.6 0.93
Delayed free recall (z-scores) 1.38 ± 0.70 0.41 ± 0.79 −0.43 ± 1.71* 0.0004
Delayed cued recall (percentiles) 35.0 ± 20.5 39.6 ± 22.4 29.7 ± 26.4 0.35
Mattis total (percentiles) 76.6 ± 19.0 68.7 ± 31.2 42.3 ± 26.7 0.0041
Attention (percentiles) 74.5 ± 17.6 67.9 ± 28.1 50.0 ± 21.5*† 0.0085
Initiation (percentiles) 63.2 ± 28.0 58.4 ± 31.4 37.2 ± 29.3* 0.082
Construction (percentiles) 50.6 ± 17.1 49.4 ± 21.3 50.7 ± 20.0 0.99
Conceptualization (percentiles) 75.9 ± 17.1 76.9 ± 18.3 56.9 ± 20.5*† 0.025
Memory (percentiles) 69.5 ± 22.2 57.3 ± 35.4 39.8 ± 30.7* 0.057
*p < 0.05 compared with NC. † p < 0.05 compared with non-MCI PD patients
FCSRT = free/cued recall selective reminding test, MCI =mild cognitive impairment, NC = normal controls,
PD = Parkinson’s disease
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demonstrated that high WMHL volume is associated with low
memory performance in PD patients, regardless of age, gender,
education status, cardiovascular risk factors, disease duration, or
dopaminergic therapy – as in our study. Additionally, we found
that EM decline was correlated with WMHL volumes in the left
prefrontal and temporal lobes, but not with lobar grey matter or
hippocampus volumes, which has never been reported in PD
patients. Higher WMHL volumes in the prefrontal lobe may
result in lower activity in the prefrontal, temporal and cingulate
cortex during EM tasks as demonstrated by Nordahl and co-
workers in healthy individuals (Nordahl et al. 2006). As in NC
(Lancaster et al. 2016) and in MCI non-PD patients (Remy et al.
2015), temporal white matter microstructure disruption due to
regional WMHL may also account for early EM impairment in
Fig. 1 Examples of manual and
automated segmentation of white
matter hyperintense lesions
according to age-related white
matter changes score (ARWMC)
on FLAIR images
Table 3 Correlations between
total WMHL volume and
neuropsychological metrics
(n = 49)
Tests ARWMC score Manual segmentation Automated segmentation
FCSRT rho p-value rho p-value rho p-value
Immediate recall −0.063 0.67 −0.05 0.76 −0.10 0.49
Free recall 1 0.11 0.45 0.01 0.95 −0.05 0.74
Cued recall 1 −0.05 0.71 −0.09 0.54 −0.15 0.31
Free recall 2 −0.07 0.64 −0.24 0.10 −0.26 0.076
Cued recall 2 −0.18 0.21 −0.41 0.0038* −0.31 0.034
Free recall 3 −0.16 0.28 −0.29 0.049 −0.33 0.020
Cued recall 3 0.04 0.80 −0.03 0.85 0.04 0.81
Delayed free recall −0.15 0.32 −0.24 0.11 −0.30 0.047
Delayed cued recall 0.04 0.78 −0.04 0.82 −0.02 0.88
Mattis total −0.08 0.62 −0.16 0.28 −0.20 0.18
Attention −0.10 0.50 −0.18 0.22 −0.10 0.49
Initiation −0.15 0.30 −0.24 0.097 −0.16 0.27
Construction 0.10 0.50 0.08 0.59 0.15 0.32
Conceptualization 0.09 0.55 0.01 0.97 −0.01 0.97
Memory −0.16 0.28 −0.22 0.15 −0.27 0.07
ARWMC = age-related white matter changes, FCSRT = free/cued recall selective reminding test, WMHL =white
matter hyperintense lesions. * indicates significant p-value when correcting for multiple testing with the
Benjamini-Hochberg method
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MCI PD patients. Spatial distribution of WMHL could thus sus-
tain EM decline in MCI PD patients. Moreover, we found that
PD patients did not have impaired verbal attention and semantic
encoding and that attention was not significantly correlated with
total or lobar WMHL volumes. This is in agreement with
Dalaker et al. (2009) who found no significant relation between
total volume or spatial distribution of WMHL and attention-
executive function in PD. Notably, the same authors did not
explore the relation between WMHL and EM testing. In three
other studies, there was no significant relation between cognitive
performance and WMHL severity (Slawek et al. 2013, 2008) or
between the progression of WMHL and progression to higher
category of cognitive impairment (Gonzalez-Redondo et al.
2012). It is worth mentioning that these studies included PD
patients with dementia and/or long disease duration, thus poten-
tially mixing CSVD and PD-related neurodegeneration effects.
Indeed, Jones and co-workers (2017) recently highlighted that
PD and cardiovascular risk factors are independent risk factors
for cognitive impairment. Sunwoo et al. (2014) also found that
total WMHL volume is an independent predictor of conversion
fromMCI to dementia in PD patients. Overall, this suggests that,
at the early stage of PD, CSVD rather than PD-related neurode-
generation could induce EM decline. At a later stage, CSVD
could still contribute to early conversion to dementia along with
PD-related neurodegeneration.
Impact of WMHL evaluation method
In a recent critical literature review, Vesely and Rektor (2016)
suggested that controversial results on the contribution of
WMHL to PD cognitive decline might be due to methodological
differences for assessing WMHL on MR images. Indeed, in PD
patients, WMHL severity has alternatively been evaluated using
qualitative (Rodriguez-Oroz et al. 2009; Ng et al. 2012) or semi-
quantitative (Beyer et al. 2006; Gonzalez-Redondo et al. 2012;
Lee et al. 2010; Slawek et al. 2008) visual rating as well as semi-
automated (Dalaker et al. 2009; Mak et al. 2015) or automated
(Sunwoo et al. 2014; Kandiah et al. 2013) volumetric estimation.
Compared with NC, we did not find higherWMHL load inMCI
PD patients using ARWMC visual rating as several previously
published studies (Gonzalez-Redondo et al. 2012; Rodriguez-
Oroz et al. 2009; Slawek et al. 2008). Usingmanual or automated
segmentation, total WMHL volume tended to be higher in MCI
PD patients than in NC, in agreement with the results of Dalaker
and co-workers (2009). Two studies (Kandiah et al. 2013;Mak et
al. 2015) additionally found higher total WMHL volume inMCI
PD patients compared with non-MCI PD patients. Although
manual segmentation was highly reproducible, the performance
of automated segmentation was excellent with a notable gain in
processing time. This provides evidence that automated WMHL
segmentation has the potential to accurately measure WMHL
volume in PD patients, as it is the case in patients with multiple
sclerosis (Fartaria et al. 2016; Gibson et al. 2010). As suggested
by Vesely and Rektor (2016), the type of WMHL estimation
method influenced the clinico-radiological correlation analysis
in our study. On the one hand, we did not find any significant
relation between ARWMC score and neuropsychological met-
rics, as most studies that used simple visual rating (Gonzalez-
Redondo et al. 2012; Rodriguez-Oroz et al. 2009). On the other
hand, we found a significant relation between EM metrics and
totalWMHLvolume using bothmanual and automated segmen-
tation. This is in agreement with three studies, including one that
used semi-quantitative visual rating (Lee et al. 2010), one that
used semi-automated volume quantification (Mak et al. 2015)
and one that used automated volume quantification (Kandiah et
al. 2013). Interestingly, we first report a correlation between EM
decline of PD patients andWMHL volumes in the left prefrontal
and temporal lobes, which can only be reliably obtained by an
automated segmentation. This overall suggests that automated
WMHL volume quantification is fast, reproducible and more
suitable to evaluate the relation between EM impairment and
CSVD severity.
Study limitations
This study has several limitations. The sample size in the clinico-
radiological correlation analysis was small (n = 49) due to the
very stringent inclusion and exclusion criteria for the elderly
patients’ population. This, however, avoided confounding factors
such as stroke, haemorrhage, or traumatic cerebral disease. Our
results were moreover independent of age, gender, educational
attainment, cardiovascular risk factors, disease duration, and do-
pamine therapy. Nevertheless larger studies are needed to con-
firm our results. Regarding the diagnosis of VP, recent recom-
mendations propose three subtypes: post-strokeVP, insidious VP
and mixed PD/CVD (Rektor et al. 2018). While post-stroke VP
patients were formally excluded from our study we used modi-
fied Zijlman’s criteria to diagnose VP patients, which fit criteria
for the insidious VP subtype. In the present study, PD patients
and mixed PD/CVD patients were enrolled in the same group
due to the absence of clear validation of these new criteria and
because nuclear medicine imaging was not available in this co-
hort. Aswe based our correlation analyses on aWMHL location-
free hypothesis, our results are still valuable. Whether automated
WMHL volume could help distinguishing between mixed PD/
CVD patients and PD patients without CVD should be investi-
gated. Longitudinal data were not recorded and are needed to
evaluate the impact ofWMHL volume on the time course of EM
decline. As discussed above, it was demonstrated that WMHL is
an independent predictor of conversion fromMCI to dementia in
PD patients (Sunwoo et al. 2014). Although Maillard et al.
(2012) demonstrated that a 1 mL/year increase in global
WMHL volume is associated with an additional 0.7 SD/year of
subsequent EM decrease in non-PD subjects, it remains unclear
whether WMHL volume follow-up could predict the individual
time course of EM decline in PD patients. While effect of
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cognitive training on memory remained uncertain in a recent
meta-analysis (Leung et al. 2015), it is also unknown whether
automatedWMHLvolumetry could be used as amarker to select
and follow-up patients who could benefit from cognitive rehabil-
itation, aggressive cardiovascular risk factors control, or other
alternative therapy. This needs further investigations.
Conclusion
Overall, our results indicate that CSVD may contribute to early
EM impairment in MCI PD patients older than 70 years. The
relation between neuropsychological metrics and CSVD severity
is influenced by the method of assessing WMHL on MRI im-
ages. Automated quantification of WMHL volume is reliable
and may have diagnostic, prognostic and therapeutic implica-
tions in PD patients.
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